Eliyahu Kavian
Physician Assistant · Brooklyn, NYNPI 1699183467
Payments from drug & device makers
Across 206 payments — averaging $23.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$797
- Otsuka America Pharmaceutical, Inc.$529
- AbbVie$396
- Takeda Pharmaceuticals U.S.A., Inc.$389
- Lilly USA, LLC$375
- Boehringer Ingelheim$301
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,72599%
- Education$241%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 27 | $797 |
| Otsuka America Pharmaceutical, Inc. | 25 | $529 |
| AbbVie | 18 | $396 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $389 |
| Lilly USA, LLC | 12 | $375 |
| Boehringer Ingelheim | 14 | $301 |
| Amgen | 6 | $252 |
| Biohaven Pharmaceuticals, Inc. | 11 | $221 |
| Biohaven Pharmaceutical Holding Company Ltd. | 12 | $185 |
| Merck | 8 | $169 |
| Exact Sciences | 7 | $137 |
| Ardelyx, Inc. | 5 | $136 |
| LNHC, Inc | 1 | $125 |
| Pfizer | 5 | $113 |
| GSK | 4 | $85 |
| Xeris Pharmaceuticals, Inc. | 3 | $54 |
| Scilex Pharmaceuticals Inc. | 3 | $53 |
| Idorsia Pharmaceuticals US Inc | 3 | $50 |
| Redhill Biopharma Inc. | 2 | $49 |
| Sanofi | 2 | $43 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $40 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $37 |
| Amarin Pharma, Inc. | 2 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Abbott | 1 | $28 |
| Sanofi Pasteur Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $22 |
| Phadia US Inc. | 1 | $18 |
| Almatica Pharma LLC | 1 | $17 |
| Renalytix AI, Inc. | 1 | $17 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Genentech USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,749 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 100 | $65,687 |
| Metformin Er GastricMetformin Hcl | 13 | $65,471 |
| OzempicSemaglutide | 39 | $36,621 |
| EliquisApixaban | 33 | $28,631 |
| MounjaroTirzepatide | 26 | $27,805 |
| JanumetSitagliptin Phos/Metformin Hcl | 30 | $21,984 |
| JanuviaSitagliptin Phosphate | 29 | $17,829 |
| FarxigaDapagliflozin Propanediol | 25 | $17,733 |
| TrulicityDulaglutide | 19 | $16,768 |
| Omeprazole-Sodium BicarbonateOmeprazole/Sodium Bicarbonate | 13 | $9,178 |
| TradjentaLinagliptin | 17 | $8,630 |
| EntrestoSacubitril/Valsartan | 11 | $7,464 |
| VascepaIcosapent Ethyl | 29 | $6,316 |
| Diclofenac Sodium | 22 | $4,734 |
| SynthroidLevothyroxine Sodium | 58 | $2,917 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $301 | $74,317117 claims |
| Lilly USA, LLCMounjaro, Trulicity | $375 | $44,57345 claims |
| MerckJanumet, Januvia | $169 | $39,81359 claims |
| PfizerEliquis | $113 | $28,63133 claims |
| AstraZenecaFarxiga | $797 | $17,73325 claims |
| AbbVieSynthroid | $396 | $2,91758 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Brooklyn
- Kaitlyn NelsonBrooklyn$289K
- Melissa VelezBrooklyn$68K
- Steven KongBrooklyn$66K
- Hong ChenBrooklyn$57K
- Lindsey AxtBrooklyn$52K
- Gregory CelestinBrooklyn$41K
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.